The paradox of clopidogrel use in patients with acute coronary syndromes and diabetes-Reference-Cited by-同舟云学术

The paradox of clopidogrel use in patients with acute coronary syndromes and diabetes

Published:2018-06 Issue:4 Volume:29 Page:309-315
ISSN:0954-6928
Container-title:Coronary Artery Disease
language:en
Short-container-title:

Author:

Ferlini Marco,Musumeci Giuseppe,Grieco Niccolò,Rossini Roberta,De Servi Stefano,Mafrici Antonio,Sponzilli Carlo,Demarchi Andrea,Assanelli Emilio M.,Camisasca Paola,Chizzola Giuliano,Corrada Elena,Farina Andrea,Pedrinazzi Claudio,Lettieri Corrado,Oltrona Visconti Luigi

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference31 articles.

1. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC);Roffi;Eur Heart J,2016

2. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation;Steg;Eur Heart J,2012

3. Resistance to clopidogrel: a review of the evidence;Nguyen;J Am Coll Cardiol,2005

4. Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial;Wiviott;Circulation,2007

5. Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study;Gurbel;Circulation,2009

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Balancing Benefits and Risks of Oral Antiplatelet Strategies in patients With Coronary Artery Diseases: An Evolving Issue;Current Problems in Cardiology;2023-12

2. Clinical implications of diabetes mellitus in patients with acute coronary syndrome: Prognostic role and use of new P2Y12 receptor inhibitors;Diabetes Research and Clinical Practice;2022-02

3. Ticagrelor is more effective than clopidogrel in carrier of nonfunctional <i>CYP2C19</i> allele who has diabetes and acute coronary syndrome - case report and literature review;AIMS Molecular Science;2022

4. Efficacy and Safety of Ticagrelor in Diabetes Patients Undergoing Percutaneous Coronary Intervention;Journal of Cardiovascular Pharmacology;2021-02-18

5. The Role of Clopidogrel in 2020: A Reappraisal;Cardiovascular Therapeutics;2020-03-27